41446 Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice is hereby given of the twentieth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

8:30 a.m. to approximately 6 p.m. on 

Thursday, October 8, 2009, and from 8 

a.m. to approximately 3:30 p.m. on 

Friday, October 9, 2009, at the Hubert H. 

Humphrey Building, 200 Independence 

Avenue, SW., Washington, DC 20201. 

The meeting will be open to the public 

with attendance limited to space 

available. The meeting also will be Web 

cast. 

The main agenda items involve the 

review of three SACGHS draft reports: a 

final draft report and its 

recommendations on gene patents and 

licensing practices along with 

comments received on the public 

consultation draft circulated earlier this 

year; a public consultation draft report 

on genetics education and training; and 

a revised draft paper on direct-toconsumer genetic testing. The first day 

of the meeting will include an extended 

period of time for interested members of 

the public to provide their perspectives 

on gene patents and licensing practices 

and their effect on patient access to 

genetic tests. Members of the public are 

encouraged to contact the SACGHS 

Executive Secretary (see below) by 

September 15, 2009, if they wish to 

participate in this extended public 

comment period. Other agenda items 

include an update on regulations 

implementing the Genetic Information 

Nondiscrimination Act, a report on 

activities of the Clinical Utility and 

Comparative Effectiveness Task Force, 

and a brief discussion to initiate the 

Committee’s work on ethical issues 

related to genomic data sharing. 

As always, the Committee welcomes 

hearing from anyone wishing to provide 

public comment on any issue related to 

genetics, health and society. Individuals 

who would like to provide public 

comment should notify the SACGHS 

Executive Secretary, Ms. Sarah Carr, by 

telephone at 301–496–9838 or e-mail at 

carrs@od.nih.gov. The SACGHS office is 

located at 6705 Rockledge Drive, Suite 

750, Bethesda, MD 20892. Anyone 

planning to attend the meeting who 

needs special assistance, such as sign 

language interpretation or other 

reasonable accommodations, is also 

asked to contact the Executive 

Secretary. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provide advice on these 

issues. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

oba.od.nih.gov/SACGHS/ 

sacghs_meetings.html. 

Dated: August 10, 2009. 

Jennifer Spaeth, 

Director, NIH Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19583 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Neurological 

Disorders and Stroke Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: September 17–18, 2009. 

Open: September 17, 2009, 10:30 a.m. to 

5:00 p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Associate Director for 

Extramural Research and other 

Administrative and Program Developments. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 10, Bethesda, MD 20892. 

Closed: September 18, 2009, 8 a.m. to 11:30 

a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Robert Finkelstein, PhD, 

Associate Director for Extramural Research, 

National Institute of Neurological Disorders 

and Stroke, NIH, 6001 Executive Blvd., Suite 

3309, MSC 9531, Bethesda, MD 20892, (301) 

496–9248. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.ninds.nih.gov, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: August 10, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–19578 Filed 8–14–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

Advisory Board on Radiation and 

Worker Health (ABRWH), National 

Institute for Occupational Safety and 

Health (NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

mstockstill on DSKH9S0YB1PROD with NOTICES